Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Vyant Bio, Inc. (VYNT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
18 Nov 2022
Harris Geoffrey E.
Director
Vyant Bio, Inc.
(VYNT)
14,685
-4%
765
$1.33
$1,021.11
BUY
6 Dec 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
128,786
+4%
5,000
$1.69
$8,450.00
BUY
24 Nov 2021
ROBERTS JOHN A
Chief Executive Officer, Officer
Vyant Bio, Inc.
(VYNT)
39,807
+14%
5,000
$2.02
$10,100.00
BUY
23 Nov 2021
LaFrence Andrew D.C.
Chief Financial Officer, Officer
Vyant Bio, Inc.
(VYNT)
34,336
+17%
5,000
$2.00
$9,997.50
BUY
22 Nov 2021
Yeh Yung-Ping
Chief Innovation Officer, Director, Officer
Vyant Bio, Inc.
(VYNT)
12,762
+4%
500
$2.05
$1,025.00
BUY
28 Oct 2021
Fremeau Robert Thomas Jr.
Chief Scientific Officer, Officer
Vyant Bio, Inc.
(VYNT)
1,000
+100%
1,000
$2.19
$2,190.00
BUY
27 Oct 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
123,786
+4%
5,000
$2.10
$10,500.00
BUY
29 Sep 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
118,786
+4%
5,000
$2.44
$12,200.00
BUY
25 Aug 2021
Yeh Yung-Ping
Chief Innovation Officer, Director, Officer
Vyant Bio, Inc.
(VYNT)
12,262
+8%
1,000
$2.64
$2,640.00
BUY
25 Aug 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
113,786
+4%
5,000
$2.58
$12,878.00
BUY
23 Aug 2021
ROBERTS JOHN A
Chief Executive Officer, Officer
Vyant Bio, Inc.
(VYNT)
34,807
+42%
10,406
$2.41
$25,078.46
BUY
19 Aug 2021
Hansen Paul R.
Director
Vyant Bio, Inc.
(VYNT)
617,957
+3%
20,000
$2.35
$47,000.00
BUY
28 Jul 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
108,786
+4%
5,000
$2.92
$14,623.50
BUY
30 Jun 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
103,929
+5%
5,000
$3.76
$18,824.50
BUY
28 May 2021
Boehm Marcus
Director
Vyant Bio, Inc.
(VYNT)
98,929
+5%
5,000
$3.68
$18,400.00
BUY
24 May 2021
ROBERTS JOHN A
Chief Executive Officer, Officer
Vyant Bio, Inc.
(VYNT)
312,117
+4%
14,481
$3.46
$50,142.75
BUY
21 May 2021
FLETCHER R JOHN
Director
Vyant Bio, Inc.
(VYNT)
30,300
+100%
30,300
$3.36
$101,783.38
BUY
20 May 2021
Yeh Yung-Ping
Chief Innovation Officer, Director, Officer
Vyant Bio, Inc.
(VYNT)
1,329,602
+0%
1,000
$3.29
$3,290.00
BUY
20 May 2021
LaFrence Andrew D.C.
Chief Financial Officer, Officer
Vyant Bio, Inc.
(VYNT)
32,336
+10%
3,000
$3.28
$9,837.00
BUY
31 Jan 2019
Cannon Edmund
Director
CANCER GENETICS, INC
(CGIX)
61,873
+2%
1,449.3
$6.90
$10,000.17
BUY
31 Jan 2019
ROBERTS JOHN A
Chief Executive Officer, Officer
CANCER GENETICS, INC
(CGIX)
297,636
+2%
6,181.2
$6.90
$42,650.28
BUY
31 Jan 2019
Miles Michael Glenn
Chief Financial Officer, Officer
CANCER GENETICS, INC
(CGIX)
150,000
+3%
5,000.001
$6.90
$34,500.00
BUY
31 Jan 2019
PAPPAJOHN JOHN
Director
CANCER GENETICS, INC
(CGIX)
4,781,204
+0%
33,333.336
$6.90
$230,000.00
BUY
14 Jan 2019
Harris Geoffrey E.
Director
CANCER GENETICS, INC
(CGIX)
127,500
+2%
3,333.334
$6.75
$22,500.00
BUY
14 Jan 2019
PAPPAJOHN JOHN
Director
CANCER GENETICS, INC
(CGIX)
3,781,204
+0%
33,333.336
$6.75
$225,000.00
BUY
14 Jan 2019
ROBERTS JOHN A
Chief Executive Officer, Officer
CANCER GENETICS, INC
(CGIX)
112,200
+3%
3,333.334
$6.75
$22,500.00
BUY
15 Dec 2017
ROBERTS JOHN A
Chief Operating Officer, Officer
CANCER GENETICS, INC
(CGIX)
12,200
+3%
406.667
$59.85
$24,339.00
BUY
8 Dec 2017
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,781,204
+0%
5,000.001
$55.80
$279,000.00
BUY
17 Aug 2017
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,608,704
+0%
2,872.834
$97.35
$279,668.47
BUY
12 Jun 2017
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,542,519
+0%
3,333.334
$112.46
$374,870.00
SELL
23 May 2017
Gitelman Igor
Chief Accounting Officer, Officer
CANCER GENETICS, INC
(CGIX)
937
-0%
0
$119.50
$62.22
BUY
16 May 2017
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,440,019
+0%
643.667
$113.91
$73,318.14
BUY
16 May 2017
Harris Geoffrey E.
Director
CANCER GENETICS, INC
(CGIX)
22,500
+0%
83.333
$112.50
$9,375.00
BUY
14 Dec 2016
Harris Geoffrey E.
Director
CANCER GENETICS, INC
(CGIX)
20,000
+0%
83.333
$45.00
$3,750.00
BUY
28 Nov 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,420,709
+0%
3,333.334
$43.58
$145,280.00
SELL
16 Nov 2016
Sitar Edward J
Chief Financial Officer, Officer
CANCER GENETICS, INC
(CGIX)
14,167
-0%
111.1
$46.74
$5,192.81
BUY
14 Nov 2016
Harris Geoffrey E.
Director
CANCER GENETICS, INC
(CGIX)
17,500
+0%
166.667
$46.50
$7,750.00
BUY
14 Nov 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,320,709
+0%
1,036.667
$44.42
$46,049.77
BUY
16 Aug 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,287,109
+0%
1,500
$68.80
$103,203.00
BUY
12 Aug 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
2,242,109
+0%
4,916.667
$64.74
$318,287.88
BUY
17 Mar 2016
McLeod Howard
Director
CANCER GENETICS, INC
(CGIX)
6,000
+0%
33.333
$81.30
$2,710.00
BUY
17 Mar 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
1,771,789
+0%
1,666.667
$79.24
$132,060.00
BUY
16 Mar 2016
SHARMA PANNA
Chief Executive Officer, Director, Officer
CANCER GENETICS, INC
(CGIX)
152,500
+0%
50
$77.80
$3,890.00
BUY
16 Mar 2016
Welsh Michael J.
Director
CANCER GENETICS, INC
(CGIX)
5,040
+0%
1.333
$72.60
$96.80
BUY
15 Mar 2016
SHARMA PANNA
Chief Executive Officer, Director, Officer
CANCER GENETICS, INC
(CGIX)
151,000
+0%
33.333
$76.80
$2,560.00
BUY
15 Mar 2016
PAPPAJOHN JOHN
Director, 10% Owner
CANCER GENETICS, INC
(CGIX)
1,721,789
+0%
3,333.334
$75.86
$252,878.11
Home